Urine Test Strips Market by Product Type (Reagent Strips, Dipsticks), Test Type (Single Parameter, Multi-Parameter), Application (Urinary Tract Infections, Diabetes, Kidney Disease, Pregnancy & Fertility, Liver Disease), End User, and Geography – Global Forecast to 2035

What is the Urine Test Strips Market Size?

The global urine test strips market was valued at USD 2.47 billion in 2024. This market is expected to reach USD 5.34 billion by 2035 from USD 2.66 billion in 2025, at a CAGR of 7.3% from 2025 to 2035. The growing prevalence of chronic diseases including diabetes and kidney disorders, increasing adoption of point-of-care testing and home-based diagnostic solutions, higher healthcare costs pushing the need for affordable screening tools, an expanding elderly population needing regular health checks, and improvements in strip sensitivity and multi-parameter testing are all boosting the use of urine test strips across hospitals, diagnostic labs, home care settings, and physician offices around the world.

Market Highlights: Urine Test Strips

• In terms of revenue, the global urine test strips market is valued at USD 2.66 billion in 2025 and is projected to reach USD 5.34 billion by 2035.
• The market is expected to grow at a CAGR of 7.3% from 2025 to 2035.
• North America dominates the global urine test strips market with the largest market share of 35-40% in 2025.
• Asia Pacific is expected to witness the fastest CAGR during the forecast period.
• By product type, the reagent strips segment holds the largest market share in 2025.
• By product type, the dipsticks segment is expected to witness steady growth during the forecast period.
• By test type, the multi-parameter strips segment holds the largest share of the overall urine test strips market in 2025.
• By test type, the multi-parameter strips segment is also expected to witness the fastest CAGR during the forecast period.
• By application, the urinary tract infections segment holds the largest market share in 2025.
• By application, the diabetes monitoring segment is expected to witness the fastest CAGR during the forecast period.
• By end user, the hospitals and clinics segment holds the largest share in 2025.
• By end user, the homecare settings segment is expected to witness the fastest CAGR during the forecast period.

Market Overview  and Insights

Click here to: Get Free Sample Pages of this Report

The urine test strips market includes the manufacturing, distribution, and use of diagnostic strips designed for qualitative and semi-quantitative analysis of urine samples. These strips help detect various health issues and metabolic problems. Urine test strips, also called urinalysis strips or dipsticks, are small plastic strips with several chemical reagent pads. These pads change color when they come into contact with certain substances in urine, like glucose, protein, blood, ketones, bilirubin, urobilinogen, pH, specific gravity, leukocytes, and nitrites. These tools are non-invasive and provide quick results in 60 to 120 seconds. They allow healthcare professionals and individuals to screen for urinary tract infections, diabetes, kidney disease, liver disorders, and other metabolic conditions without needing lab equipment or specialized training.

The market includes single-parameter strips that test for one specific substance, as well as multi-parameter strips that can detect 2 to 14 different parameters at once. These are available in various formats, such as individual strips, vials with multiple strips, and strips compatible with automated readers for digital results. The market is growing due to the increasing global burden of chronic diseases that need regular monitoring. There is also a rising preference for point-of-care testing, which cuts down lab turnaround times and boosts clinical decision making. The factors such as rising healthcare spending in emerging economies that improve access to diagnostic tools, aging populations with more metabolic disorders and infections, advancements in technology that enhance strip accuracy and shelf life, and a trend towards home healthcare that supports self-monitoring and proactive health management for a wide range of patients further drive the growth of this market.

What are the Key Trends in the Urine Test Strips Market?

Home-based health monitoring adoption: A major trend in the urine test strips market is the rapid growth of consumer use of home health monitoring. This shift is driven by rising health awareness, a preference for convenience, and the desire for proactive disease management without frequent visits to clinics. The easy availability of urine test strips for diabetes monitoring, urinary tract infection detection, pregnancy testing, and general wellness checks allows individuals to perform regular self-assessments and seek medical help when they notice unusual results. The COVID-19 pandemic sped up this trend by showing the benefits of remote health monitoring and decreasing unnecessary visits to healthcare facilities. Manufacturers are creating user-friendly products with simple instructions, clear color charts, and smartphone compatibility, making home testing easy for those without medical backgrounds. This trend is especially strong among diabetics who need to check their ketone and glucose levels often, women monitoring pregnancy and fertility, and older adults managing chronic conditions. Telehealth allows healthcare providers to guide home testing methods and interpret results from afar, broadening clinical care outside of traditional settings. This approach also reduces healthcare costs and encourages patients to take an active role in managing their health.

Multi-parameter testing expansion: Another key trend driving market growth is the move toward multi-parameter urine test strips. These strips provide more diagnostic information from a single test. This improves clinical efficiency and diagnostic accuracy while lowering per-test costs. Healthcare providers are increasingly choosing 10-14 parameter strips that can screen for multiple conditions at once. This approach replaces the need for separate single-parameter tests. It allows for a thorough metabolic assessment during routine check-ups, pre-surgical screenings, and chronic disease monitoring.

These advanced multi-parameter strips can detect traditional markers like glucose, protein, and blood. They also include specialized parameters such as microalbumin for early detection of diabetic nephropathy, creatinine for kidney function assessment, and specific gravity for evaluating hydration status. This trend supports preventive care and early disease detection by spotting subtle abnormalities that limited testing might miss. The cost-effectiveness of comprehensive screening compared to selective testing, along with the quick availability of results, helps healthcare facilities make immediate clinical decisions. This drives the standardization of multi-parameter strips for routine urinalysis and increases market value, even if it means lower unit volumes compared to basic testing methods.

Market Scope

Market Dynamics

Drivers

Rising Prevalence of Chronic Diseases Requiring Regular Urinalysis

A key factor driving the growth of the urine test strips market is the rising global burden of chronic diseases, including diabetes, chronic kidney disease, urinary tract infections, and liver disorders. These conditions require frequent urine testing for disease management and preventing complications. The International Diabetes Federation reports that around 537 million adults worldwide live with diabetes. This number is expected to reach 783 million by 2045, creating ongoing demand for urine glucose and ketone monitoring. These tests help detect diabetic ketoacidosis and assess glycemic control.

Chronic kidney disease affects about 10% of the global population. Early detection through urinary protein and albumin testing is vital. It helps slow disease progression and prevents end-stage renal failure that necessitates dialysis. Urinary tract infections are among the most common bacterial infections, impacting millions every year. These infections require quick diagnosis through leukocyte and nitrite detection to start appropriate antibiotic therapy.

The aging global population sees a higher incidence of these conditions. Elderly individuals often manage multiple health issues that need regular monitoring. Healthcare systems are placing greater focus on preventive care and early intervention strategies. These strategies rely on accessible, cost-effective screening tools like urine test strips to identify disease markers before symptoms worsen. The ability to conduct routine screenings in various settings, such as primary care offices, pharmacies, nursing homes, and home environments, makes urine test strips essential for managing the growing burden of chronic diseases and lowering healthcare costs linked to delayed diagnosis and disease complications.

Opportunity

Expanding Point-of-Care Testing in Emerging Markets

The rapid growth of point-of-care testing infrastructure in emerging markets across Asia-Pacific, Latin America, and Africa offers significant opportunities for the urine test strips market. Developing regions face many healthcare access challenges. These include limited lab infrastructure, a lack of trained personnel, long distances between rural populations and diagnostic facilities, and tight healthcare budgets that limit investments in expensive lab equipment.

Urine test strips help meet these challenges by offering affordable, equipment-free diagnostic options. They can be used in primary health centers, mobile clinics, pharmacies, and community health worker programs, reaching underserved populations. Economic development and a growing middle class in countries such as India, China, Brazil, Indonesia, and Nigeria are increasing spending on healthcare and expanding insurance coverage that includes basic diagnostic tests.

Government programs promoting universal healthcare and non-communicable disease screening create favorable conditions for adopting point-of-care diagnostics. The rising rates of diabetes, kidney disease, and infectious diseases in these areas, along with limited access to traditional lab services, make urine test strips essential for disease surveillance, screening programs, and chronic disease management at the community level. Manufacturers are creating cost-effective products suited for resource-limited settings, building local distribution networks, and partnering with government and non-government health organizations to increase market reach in fast-growing emerging economies, where much of the global population growth and disease burden is occurring.

Product Type Insights

Why Do Reagent Strips Dominate the Market?

The reagent strips segment holds the largest share of around 70-75% of the overall urine test strips market in 2025. This dominance is mainly due to their versatility, cost-effectiveness, and suitability for both manual visual reading and automated analyzer use in various healthcare settings.

The reagent strips come in various configurations, ranging from basic 2-parameter strips to detailed 14-parameter panels. This variety enables healthcare facilities to choose the right level of testing complexity based on their clinical needs and budget. The segment also gains from extensive clinical validation, regulatory approvals, and established reimbursement pathways in most healthcare systems.

Major manufacturers provide reagent strips in different packaging options, including single strips for point-of-care use and bulk containers for labs, catering to various end-user needs. The reliability, maturity, and cost-efficiency compared to other urinalysis methods maintain the dominance of reagent strips in global markets.

However, the dipsticks segment continues to grow steadily during the forecast period, with the rising over-the-counter market for home health testing, where simple single-purpose or basic multi-parameter strips attract non-professional users looking for easy health monitoring tools without needing to interpret complicated multi-parameter results.

Test Type Insights

How Do Multi-Parameter Strips Lead the Market?

The multi-parameter strips segment holds the largest share of the overall urine test strips market in 2025 and is also expected to grow the fastest through 2035. This growth is mainly due to their wide diagnostic ability, clinical efficiency, and cost-effectiveness when compared to performing several single-parameter tests.

These strips can test for 10 to 14 parameters at once, including glucose, protein, pH, specific gravity, blood, ketones, bilirubin, urobilinogen, nitrites, and leukocytes. They offer extensive metabolic and infection screening from a single urine sample and test. Healthcare providers prefer multi-parameter testing for routine health checks, pre-surgical assessments, emergency department evaluations, and chronic disease monitoring.

Technological advances have improved reagent stability, reduced cross-reactivity between adjacent pads, and enhanced color differentiation, making these strips more reliable for clinical decisions. The growth of this segment is further driven by increasing use in chronic disease management programs, especially for diabetes and kidney disease patients who need regular monitoring of multiple parameters to evaluate disease progression and treatment effectiveness.

Application Insights

How Do Urinary Tract Infections Drive Market Demand?

Based on application, the urinary tract infections segment holds the largest market share in 2025. UTI detection is the most common use for urine test strips due to the high rate of urinary tract infections in all age groups. This affects an estimated 150 million people worldwide each year, with women facing a significantly higher risk and recurrence.

The application includes children, pregnant women who need regular UTI screenings, older adults at greater risk of infections, catheterized patients, and otherwise healthy adults who have sudden symptoms. People with recurrent UTIs often use home test strips to tell the difference between infection recurrence and other causes of urinary symptoms. This helps them decide whether to manage their care at home or seek medical help. The segment benefits from clear clinical use, strong evidence for the accuracy of strip-based screening, and established clinical protocols that include urine strip testing in UTI diagnosis across healthcare settings globally.

The diabetes monitoring segment, however, is expected to grow at the fastest CAGR during the forecast period. Diabetes applications are growing rapidly due to the global diabetes epidemic. The prevalence is increasing rapidly in both developed and developing countries because of aging populations, obesity, inactive lifestyles, and changes in diet.

End User Insights

Why Do Hospitals and Clinics Lead the Market?

The hospitals and clinics segment holds the largest share of about 40-45% in 2025. These settings lead the market because of their high patient volumes, regular use of urinalysis in standard care, and various needs across emergency departments, inpatient wards, outpatient clinics, surgical assessments, and specialist practices. Hospitals perform millions of urinalyses each year for admission screenings, infection diagnosis, chronic disease monitoring, medication side effect checks, and pre-procedural clearances, creating a strong and steady demand for urine test strips.

The homecare settings segment is expected to grow at the fastest CAGR through 2035, mainly due to trends in consumer empowerment, preferences for convenience, cost factors, and an increasing number of chronic disease patients needing frequent monitoring that isn’t practical in clinics.

U.S. Urine Test Strips Market Size and Growth 2025 to 2035

The U.S. urine test strips market is projected to grow at a CAGR of 6.9% from 2025 to 2035.

How is North America Maintaining Dominance in the Urine Test Strips Market?

North America holds the largest share of 35-40% of the global urine test strips market in 2025. This is mainly due to its strong healthcare infrastructure, high spending on healthcare, widespread use of point-of-care testing, supportive reimbursement policies, and a significant burden of chronic diseases driving continuous demand for testing. The U.S. is home to the biggest market for urine test strips. It has extensive networks of hospitals, physician offices, urgent care facilities, and diagnostic labs conducting millions of urinalyses each year for various clinical reasons. The high rates of diabetes and obesity in North America create a strong need for metabolic screening and monitoring.

Which Factors Support the Asia Pacific Urine Test Strips Market Growth?

Asia Pacific is expected to witness the fastest growth from 2025 to 2035. This growth is mainly attributed to the increasing burden of chronic diseases, especially diabetes and kidney disease, in heavily populated countries like China, India, Indonesia, and other Southeast Asian nations moving toward non-communicable diseases. Economic development and a growing middle class in the region are improving access to healthcare, insurance coverage, and the ability to afford diagnostic services, including routine urinalysis. Government health programs in countries such as China and India are promoting diabetes screening, kidney disease detection, and infectious disease surveillance, which increases the demand for cost-effective diagnostic tools.

The large and aging population in the region drives the need for managing chronic diseases and regular health monitoring. Limited laboratory infrastructure in rural and remote areas makes urine test strips a practical diagnostic solutions that need minimal equipment and training. Rising health awareness and growing patient empowerment further boost consumer demand for home testing products. Expanding pharmacy networks and e-commerce platforms make these strips more accessible in urban and semi-urban areas.

Additionally, the growth of medical tourism in countries like Thailand, Singapore, and India also increases the utilization of healthcare facilities and the volume of diagnostic testing. Additionally, the lower baseline penetration compared to developed markets shows significant potential for growth as awareness, affordability, and access continue to improve.

Recent Developments

• March 2025 – Siemens Healthineers received CE Mark approval for the Clinitek Novus Pro analyzer, featuring dry-pad urine chemistry technology and enhanced digital imaging for automated urine test strip reading, designed for point-of-care and laboratory applications.
• February 2025 – Roche Diagnostics continued enhancements to its Combur-Test strip line, focusing on improved reagent stability and extended shelf life, with maintained sensitivity for early detection of kidney disease markers, including microalbumin.
• January 2025 – Abbott Laboratories expanded its Choiceplus urinalysis strip portfolio with pregnancy-specific multi-parameter strips combining traditional urinalysis parameters with hCG detection for comprehensive prenatal screening in clinical settings.
• November 2024 – Arkray Inc. pursued strategic partnerships with major pharmacy chains across Asia to broaden over-the-counter availability of consumer-friendly urine test strips, complemented by mobile app support for home health monitoring.
• September 2024 – Sysmex Corporation promoted its UF-5000 Plus automated urinalysis system, integrating test strip reading with fluorescence flow cytometry, and microscopy capabilities, providing comprehensive urine analysis workflows for high-volume laboratories.

Segments Covered in the Report

By Product Type

• Reagent Strips
• Dipsticks

By Test Type

• Single Parameter Strips
  • Glucose
  • Protein
  • pH
  • Ketones
  • Blood
  • Others
• Multi-Parameter Strips

By Application

• Urinary Tract Infections
• Diabetes Monitoring
• Kidney Disease
• Pregnancy and Fertility
• Liver Disease
• General Health Screening
• Others

By End User

• Hospitals and Clinics
• Diagnostic Laboratories
• Homecare Settings
• Physician Offices
• Long-Term Care Facilities
• Research and Academic Institutes
• Others

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Frequently Asked Questions